An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Phase of Trial: Phase III
Latest Information Update: 17 Nov 2016
At a glance
- Drugs Rovatirelin (Primary)
- Indications Spinocerebellar ataxias
- Focus Therapeutic Use
- 11 Nov 2016 Status changed from not yet recruiting to recruiting.
- 31 Aug 2016 Status changed from planning to not yet recruiting.
- 01 Jun 2016 New trial record